Clinical Trial Update: Efficacy of Pioglitazone and Fortamet Combination Therapy in Subjects With Type 2 Diabetes [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating the efficacy of combining pioglitazone with Fortamet (metformin extended-release) in adults with Type 2 Diabetes Mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Fortamet (metformin hydrochloride extended-release)
• PIOGLITAZONE (Pioglitazone)

Snippet

Sponsor: Takeda | Conditions: Diabetes Mellitus | Phase 4 | Status: COMPLETED